CSPC Innovation Pharmaceutical Co (SZSE:300765) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CSPC Innovation Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. CSPC Innovation Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

CSPC Innovation Pharmaceutical Co's long-term debt to total assets ratio stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

CSPC Innovation Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for CSPC Innovation Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Innovation Pharmaceutical Co LT-Debt-to-Total-Asset Chart

CSPC Innovation Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

CSPC Innovation Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

CSPC Innovation Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

CSPC Innovation Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.841	/	5632.124
	=	0.00

CSPC Innovation Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0.214	/	5718.367
	=	0.00

CSPC Innovation Pharmaceutical Co (SZSE:300765) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

CSPC Innovation Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of CSPC Innovation Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Innovation Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » CSPC Innovation Pharmaceutical Co Ltd (SZSE:300765) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

No. 36, Fuqiang West Road, Yucheng District, Hebei, Shijiazhuang, CHN, 051430

Website

http://www.xnwpharma.net

CSPC Innovation Pharmaceutical Co Ltd is engaged in Research and development, production and sales of functional foods.

Executives

Wang Hui

Director

CSPC Innovation Pharmaceutical Co Headlines

No Headlines